Literature DB >> 8692870

A novel function for Myc: inhibition of C/EBP-dependent gene activation.

S Mink1, B Mutschler, R Weiskirchen, K Bister, K H Klempnauer.   

Abstract

We have investigated the effect of the v-Myc oncoprotein on gene expression in myelomonocytic cells. We find that v-Myc dramatically down-regulates the expression of myelomonocytic-specific genes, such as the chicken mim-1 and lysozyme genes, both of which are known targets for C/EBP transcription factors. We present evidence that Myc downregulates these genes by inhibiting the function of C/EBP transcription factors. Detailed examination of the inhibitory mechanism shows that amino-terminal sequences of v-Myc, but not its DNA-binding domain, are required for the suppression of C/EBP-dependent transactivation. Our findings identify a new function for Myc and reveal a novel mechanism by which Myc affects the expression of other genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692870      PMCID: PMC39078          DOI: 10.1073/pnas.93.13.6635

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression.

Authors:  S J Triezenberg; R C Kingsbury; S L McKnight
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

2.  Coordinate regulation of myelomonocytic phenotype by v-myb and v-myc.

Authors:  G Symonds; K H Klempnauer; M Snyder; G Moscovici; C Moscovici; J M Bishop
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

Review 3.  Oncogenes in retroviruses and cells: biochemistry and molecular genetics.

Authors:  K Bister; H W Jansen
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

4.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

5.  Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene.

Authors:  G Symonds; K H Klempnauer; G I Evan; J M Bishop
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

6.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

7.  Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins.

Authors:  W C Yeh; Z Cao; M Classon; S L McKnight
Journal:  Genes Dev       Date:  1995-01-15       Impact factor: 11.361

8.  Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein.

Authors:  E H Birkenmeier; B Gwynn; S Howard; J Jerry; J I Gordon; W H Landschulz; S L McKnight
Journal:  Genes Dev       Date:  1989-08       Impact factor: 11.361

9.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.

Authors:  J I Daksis; R Y Lu; L M Facchini; W W Marhin; L J Penn
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

10.  Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2.

Authors:  H W Jansen; B Rückert; R Lurz; K Bister
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  18 in total

1.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  An alternative pathway for gene regulation by Myc.

Authors:  K Peukert; P Staller; A Schneider; G Carmichael; F Hänel; M Eilers
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis.

Authors:  Q Xiao; G Claassen; J Shi; S Adachi; J Sedivy; S R Hann
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.

Authors:  M Hartl; F Reiter; A G Bader; M Castellazzi; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  C/EBPbeta (NF-M) is essential for activation of the p20K lipocalin gene in growth-arrested chicken embryo fibroblasts.

Authors:  S Kim; P L Mao; M Gagliardi; P A Bédard
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

7.  Genomic characterization of human and rat prolactinomas.

Authors:  Yunguang Tong; Yun Zheng; Jin Zhou; Nelson M Oyesiku; H Phillip Koeffler; Shlomo Melmed
Journal:  Endocrinology       Date:  2012-05-25       Impact factor: 4.736

8.  C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.

Authors:  John A Pulikkan; Philomina S Peramangalam; Viola Dengler; Phoenix A Ho; Claude Preudhomme; Soheil Meshinchi; Maximilian Christopeit; Oliver Nibourel; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

9.  c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.

Authors:  M K Mateyak; A J Obaya; J M Sedivy
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

10.  Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1).

Authors:  Markus Hartl; Andrea Nist; M Imran Khan; Taras Valovka; Klaus Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.